Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 346

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Association of C‐erb B‐2 protein over‐expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long‐term survival in breast cancer

Kallioniemi, Olli‐P., Holli, Kaija, Visakorpi, Tapio, Koivula, Timo, Helin, Heikki H., Isola, Jorma J. · 1991 · International Journal of Cancer

Abstract

C‐erb B‐2 protein over‐expression was studied immunohis‐tochemically in 319 paraffin‐embedded breast carcinomas representing 89% of all breast‐cancer cases operated in the Tampere University Hospital between 1977 and 1981. The immunohistochemical evaluation of c‐erb B‐2 was optimized using protease pre‐treatment and verified using antibodies for both the external and the internal domains of the protein. c‐erb B‐2 over‐expression was found in 72 (23%) of the 319 cases and was associated with high histological and nuclear grade (p< 0.0001), DNA aneuploidy (p= 0.003), high tumor S‐phase fraction (p< 0.000l), and lack of estrogen (p< 0.0001) and progesterone (p= 0.03) receptors. Overall, breast‐cancer patients with c‐erb B‐2 over‐expression had about 2.2‐fold relative risk (RR) of death (p< 0.001) as compared with those without over‐expression. According to a multivariate analysis, c‐erb B‐2 over‐expression was an independent prognostic factor in the whole material as well as in the node‐negative sub‐set. In node‐negative breast‐cancer tumor size, S‐phase and c‐erb B‐2 status defined a large patient group with only 4% 5‐year and 15% 10‐year mortality rate without adjuvant therapy. In comparison with c‐erb B‐2‐negative tumors, those with over‐expression of this gene metastasized 3 times more often (p= 0.0002) to the lungs, liver and brain and 3 times less often to the bone. Our findings suggest that the prognostic value of c‐erb B‐2 over‐expression may be related not only to increased cell proliferation rate but also to a distinctive pattern of metastasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.2910490504

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

Metadata

Authors
Kallioniemi, O., Holli, K., Visakorpi, T., Koivula, T., Helin, H. H., & Isola, J. J.
Venue
International Journal of Cancer
Publisher
Wiley
Published
1991-11-11
Volume
49
Issue
5
Pages
650-655
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2061563172
Cited by
346
References
22
FWCI
6.13
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.